跳至主要内容
临床试验/EUCTR2018-000142-18-FI
EUCTR2018-000142-18-FI进行中(未招募)1 期

Feasibility and pharmacodynamics of subcutaneously given combination of dexmedetomidine and ketamine infusion in ALS patients receiving palliative care

Turku University Hospital0 个研究点目标入组 20 人开始时间: 2018年5月8日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Diagnosed ALS
  • 2.Age = 18 years
  • 3.Written informed consent from the patient or adjacent
  • 4.Finnish spoken as mother language
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1.Previous history of intolerance to the study drug or related compounds and additives.
  • 2.Significant cognitive dysfunction or lack of ability to communicate
  • 3.Psychological or other emotional problems that are likely to invalidate informed consent, or limit the ability of the subject to comply with the protocol requirements.

研究者

相似试验